Literature DB >> 1999505

Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.

T Yoneda1, M A Alsina, J B Chavez, L Bonewald, R Nishimura, G R Mundy.   

Abstract

Recently, we have established a human squamous cell carcinoma of the maxilla (called MH-85) associated with hypercalcemia, leukocytosis, and cachexia in culture. MH-85 tumor cells caused the same paraneoplastic syndromes in tumor-bearing nude mice. We found that there was a sixfold increase in splenic size in MH-85 tumor-bearing mice. This increase paralleled tumor growth and was reversed by surgical removal of the tumor. Splenectomy in nude mice 1 wk before or 6 wk after tumor inoculation resulted in a decrease in tumor growth, and impairment of hypercalcemia, leukocytosis, and cachexia. In MH-85 tumor-bearing animals that had been pretreated by splenectomy, intravenous injection of fresh normal spleen cells caused an immediate reversal of leukocytosis, hypercalcemia, and cachexia. Since the presence of cachexia in both the patient and the mice carrying the tumor suggested tumor necrosis factor (TNF) may be overproduced, we injected polyclonal neutralizing antibodies raised against murine TNF into tumor-bearing mice. There was a rapid and reproducible decrease in blood ionized calcium, accompanied by suppression of osteoclast activity. No changes in blood ionized calcium were seen in mice injected with normal immune sera. In addition, there was an increase in body weight and decrease in white cell count. Plasma immunoreactive TNF was increased almost fourfold in tumor-bearing nude mice compared with control nude mice. Although TNF activity was undetectable in MH-85 culture supernatants, cells of the macrophage lineage, including spleen cells, released increased amounts of TNF when cultured with MH-85 tumor-conditioned media. These results suggest that splenic cytokines such as TNF may influence the development of the paraneoplastic syndromes of hypercalcemia, leukocytosis, and cachexia in these animals, as well as tumor growth. They also show that paraneoplastic syndromes may be due to factors produced by normal host cells stimulated by the presence of the tumor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999505      PMCID: PMC329890          DOI: 10.1172/JCI115106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  A SIMPLE ORGAN CULTURE METHOD WHICH ALLOWS SIMULTANEOUS ISOLATION OF SPECIFIC TYPES OF CELLS.

Authors:  F C JENSEN; R B GWATKIN; J D BIGGERS
Journal:  Exp Cell Res       Date:  1964-05       Impact factor: 3.905

2.  A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE.

Authors:  E J LAPPAT; M CAWEIN
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Kinetics of cell proliferation of an experimental tumor.

Authors:  E Frindel; E P Malaise; E Alpen; M Tubiana
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

5.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

6.  Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.

Authors:  Y X Fu; G Watson; J J Jimenez; Y Wang; D M Lopez
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

7.  Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor.

Authors:  M Sabatini; J Chavez; G R Mundy; L F Bonewald
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

8.  Granulocytosis and colony-stimulating activity (CSA) produced by a human squamous cell carcinoma.

Authors:  N Sato; S Asano; Y Ueyama; M Mori; T Okabe; Y Kondo; N Ohsawa; K Kosaka
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

9.  Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B.

Authors:  D M Jacobs; D C Morrison
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

Authors:  H Kirchner; T M Chused; R B Herberman; H T Holden; D H Lavrin
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  22 in total

1.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

2.  Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.

Authors:  T Michigami; M Nomizu; Y Yamada; C Dunstan; P J Williams; G R Munday; T Yoneda
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

3.  Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha.

Authors:  M Buck; L Zhang; N A Halasz; T Hunter; M Chojkier
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 4.  Pancreatic cancer and hypercalcemia associated with von Recklinghausen's disease.

Authors:  M Yamamoto; S Nakano; M Mugikura; I Tachibana; Y Ogami; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

5.  Local control of osteoclast function.

Authors:  G R Mundy
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 6.  Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package.

Authors:  Ankur Bahl; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2012-04-28       Impact factor: 1.967

7.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

8.  The presence of tumor necrosis factor-alpha and its antibody in the sera of cachexic patients with gastrointestinal cancer.

Authors:  T Kiyama; M Onda; A Tokunaga; I Fujita; T Okuda; T Mizutani; N Matsukura; Y Todome; H Ohkuni
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; C E Plester; J A Ross; D C Carter
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

10.  Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.

Authors:  T Yoneda; C Lowe; C H Lee; G Gutierrez; M Niewolna; P J Williams; E Izbicka; Y Uehara; G R Mundy
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.